- Ralph Lauren (NYSE:RL) is tapped for more even more gains after rallying sharply following last week's announcement of the resignation of CEO Ralph Lauren. New CEO Stefan Larsson is seen adding some fast-fashion punch to the luxury mindset at the company.
- Tenet Healthcare (NYSE:THC) could rise as much as 70% with mergers expected to start feeding the bottom line, observes Barclays. Concerns over Tenet's debt load has driven shares down sharply to levels seen as attractive.
- Margins at Boston Scientific (NYSE:BSX) are expected to improve with new products looking promising. The consensus price target on Wall Street implies close to a 20% gain is in store.